Project Grant W911SR261A003
- This $324,493.13 Project Grant awarded by the Defense Health Agency on February 21, 2025 supports research and development of novel repellent textiles that can provide protection from disease vectors for the U.S. Army. The funded work, which is part of the Department of Defense's Pest Management and Vector Control Research program (CFDA 12.355), will further advance Anovoteks' technology for creating repellent fabrics for Army combat uniforms and modular lightweight load-carrying equipment....
- This Project Grant award from the Department of Defense's Pest Management and Vector Control Research program (CFDA 12.355) provides $310,124.67 to The Ohio State University to develop novel, safe pesticides from a rubber-producing plant (guayule) for controlling medically relevant mosquitoes. The research project aims to produce prototype technologies for advanced technology development to protect deployed military personnel from arthropod-borne diseases. The award commenced on January 21, 2025...
- The Department of Defense, through its Pest Management and Vector Control Research program (CFDA 12.355), awarded a $330,363 Project Grant to Athena Vector Technology LLC in Alpharetta, GA. The grant agreement, effective January 5, 2026, supports the development and commercialization of a mechanical mode of action insecticide for effective tick and arthropod control, mitigating vector-borne pathogen transmission to humans. This product-oriented research is expected to deliver prototype...
- The U.S. Department of the Army Medical Command awarded a $325,000.03 Project Grant to The Mentor Initiative, a non-profit organization registered in the United Kingdom, under the Deployed Warfighter Protection (DWFP) Program (CFDA 12.355). The grant funding is for research and development efforts aimed at reducing filth fly populations and transmission of diarrheal pathogens in harsh settings. The project will run from December 20, 2024 to December 20, 2027. The DWFP Program supports the...
- This $819,195 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Drexel University on the PEDF PLXDC1 ADNP signaling pathways related to neuromorphogenesis and neural circuit development. The award, which runs from September 15, 2023 to September 14, 2026, will fund basic, translational, and clinical research aimed at advancing scientific understanding and developing new treatments in areas such as...
- This $1,161,428 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a fully automated, multimodal, and multiplexed ferrobotic system for point-of-care pathogenic and serological tick-borne disease diagnosis. The award, granted to the University of California, Los Angeles (UCLA), aims to advance biomedical research and transform healthcare for military service members, veterans, and the general public....
- This Project Grant award of $668,038.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Drexel University's research on "BIOMIMETIC NANOPARTICLE-MEDIATED DELIVERY OF IMMUNOMODULATING NUCLEIC ACIDS AS A STRATEGY TO ANTICIPATE MELANOMA DRUG RESISTANCE." The 3-year project aims to develop innovative nanoparticle-based therapies to overcome drug resistance in melanoma treatment. As a private research university, Drexel has a...
- The U.S. Defense Health Agency awarded a $384,063 Project Grant to The Pennsylvania State University (Penn State) under the Military Medical Research and Development program (CFDA 12.420). The grant provides funding from February 1, 2025 through January 31, 2027 for a project titled "Direct Genetic Modification of Plasmodium Sporozoites by mRNA/Lipid Nanoparticles". The project aims to conduct advanced biomedical research into innovative medical solutions to address critical health...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $542,247 to Fraunhofer USA, Inc. to develop boron-doped diamond electrode arrays for malaria detection in saliva and urine. The award period runs from March 1, 2025 to February 28, 2027. Fraunhofer USA, Inc. is a non-profit research organization specializing in advanced materials research and development, with expertise in diamond technologies and...
- This Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The $588,514 grant is funding research at the University of California, San Diego (UCSD) to develop new tools and technologies for mosquito control, with a focus on Aedes aegypti, an important disease vector. The key objectives are to evaluate conditional and sex-specific lethal systems that can...
This federal Project Grant award from the Defense Health Agency, under the Pest Management and Vector Control Research program (CFDA 12.355), provides $267,319.71 to Drexel University to develop 2D materials for protection against mosquito-borne disease. The research aims to create new interventions to protect deployed military personnel from arthropod-borne diseases and improve vector control technologies. The funding will support a 3-year effort, starting on January 12, 2026, with a final completion date of January 13, 2029. This grant reflects the Defense Health Agency's focus on developing innovative approaches to prevent the transmission of insect-borne diseases, which is a critical priority for protecting military forces deployed in areas with high disease risks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $267.3k | 12/11/25 |